Summary
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Radiopharmaceuticals in Nuclear Medicine , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Radiopharmaceuticals in Nuclear Medicine market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
Asia-Pacific (China, India, Japan, Southeast Asia etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
By End-User / Application
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Others
By Company
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Table of Contents
Part 1 Market Definition
1.1 Market Segment Overview
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size (Million USD) 2017-2025
1.2 by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Market and Growth by Type
1.3 by End-Use / Application
Table Global Radiopharmaceuticals in Nuclear Medicine Market and Growth by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Vendors (2017-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Vendors (2017-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Volume (Volume) by Vendors (2017-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Volume Share by Vendors (2017-2019)
2.2 Vendor Profile
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
Table Global Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by Type (2017-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type (2017-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Volume (Volume) by Type (2017-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Volume Share by Type (2017-2019)
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
Table Global Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by End-Use / Application (2017-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Share by End-Use / Application (2017-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Volume Share by End-Use / Application (2017-2019)
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
Table Global Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by Regions (2017-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Share by Regions (2017-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Volume (Volume) by Regions (2017-2019)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Volume Share by Regions (2017-2019)
5.2 Regional Market Growth
5.2.1 North America
Figure North America Market Growth 2015-2018
5.2.2 Europe
Figure Europe Market Growth 2017-2019
5.2.3 Asia-Pacific
Figure Asia-Pacific Market Growth 2017-2019
5.2.4 South America
Figure South America Market Growth 2017-2019
5.2.5 Middle East & Africa
Figure Middle East & Africa Market Growth 2017-2019
6 North America Market
6.1 by Type
Table North America Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by Type (2017-2019)
Table North America Radiopharmaceuticals in Nuclear Medicine Market Share by Type (2017-2019)
6.2 by End-Use / Application
Table North America Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by End-Use / Application (2017-2019)
Table North America Radiopharmaceuticals in Nuclear Medicine Market Share by End-Use / Application (2017-2019)
6.3 by Regions
Table North America Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by Regions (2017-2019)
Table North America Radiopharmaceuticals in Nuclear Medicine Market Share by Regions (2017-2019)
7 Europe Market
7.1 by Type
Table Europe Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by Type (2017-2019)
Table Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Type (2017-2019)
7.2 by End-Use / Application
Table Europe Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Radiopharmaceuticals in Nuclear Medicine Market Share by End-Use / Application (2017-2019)
7.3 by Regions
Table Europe Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by Regions (2017-2019)
Table Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Regions (2017-2019)
8 Asia-Pacific Market
8.1 by Type
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Type (2017-2019)
8.2 by End-Use / Application
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by End-Use / Application (2017-2019)
8.3 by Regions
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Regions (2017-2019)
9 South America Market
9.1 by Type
Table South America Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by Type (2017-2019)
Table South America Radiopharmaceuticals in Nuclear Medicine Market Share by Type (2017-2019)
9.2 by End-Use / Application
Table South America Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by End-Use / Application (2017-2019)
Table South America Radiopharmaceuticals in Nuclear Medicine Market Share by End-Use / Application (2017-2019)
9.3 by Regions
Table South America Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Regions (2017-2019)
10 Middle East & Africa Market
10.1 by Type
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Type (2017-2019)
10.2 by End-Use / Application
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Share by End-Use / Application (2017-2019)
10.3 by Regions
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Regions (2017-2019)
11 Market Forecast
11.1 Global Market Forecast (2020-2025)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Volume (Volume) and Growth Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
Table Global Radiopharmaceuticals in Nuclear Medicine Market (Million USD) Forecast by Regions (2020-2025)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Regions (2020-2025)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Volume Share Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
Table Global Radiopharmaceuticals in Nuclear Medicine Market (Million USD) Forecast by Type (2020-2025)
Table Global Radiopharmaceuticals in Nuclear MedicineMarket Share by Forecast Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
Table Global Radiopharmaceuticals in Nuclear Medicine Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
12.BRAE Bracco Imaging S.P.A.
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Table Sales Revenue, Volume, Price, Cost and Margin of Bracco Imaging S.P.A.
12.2 Cambridge Isotope Laboratories, Inc.
12.3 Cardinal Health, Inc.
12.4 Covidien, Plc
12.5 Eczacibasi-Monrol
12.6 Fujifilm Holdings Corporation
12.7 GE Healthcare (Subsidiary Of General Electric Company)
12.8 IBA Group
12.9 Isotec, Inc. (Sigma-Aldrich)
12.10 Lantheus Medical Imaging, Inc.
12.11 Nordion, Inc.
12.12 Ntp Radioisotopes (Pty), Ltd.
12.13 Siemens Healthcare (Subsidiary Of Siemens AG)
12.14 Taiyo Nippon Sanso Corporation
12.15 Urenco Limited
12.16 Rotem Industries, Ltd., Inc.
12.17 Australian Nuclear Association And Technology Organization (ANSTO)
12.18 Board of Radiation And Isotope Technology (BRIT)
12.19 Institute of Atomic Energy Polatom Radioisotope Centre
12.20 Institute of Isotopes Co., Ltd.
12.21 Institute Of Radioelement (IRE)
13 Overview of Industry Development (COVID-19)
13.1 Analysis of Industry Development (COVID-19)
13.2 Industry Development Stage (COVID-19)
13.3 General Situation of Industry Development (COVID-19)
13.4 Analysis of Industry Development Characteristics (COVID-19)
14 Research Conclusion